208 related articles for article (PubMed ID: 31677131)
1. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
Nakagawa T; Sato Y; Tanahashi T; Mitsui Y; Kida Y; Fujino Y; Hirata M; Kitamura S; Miyamoto H; Okamoto K; Muguruma N; Bando Y; Takayama T
Gastric Cancer; 2020 May; 23(3):426-436. PubMed ID: 31677131
[TBL] [Abstract][Full Text] [Related]
2. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract][Full Text] [Related]
3. JMJD2A predicts prognosis and regulates cell growth in human gastric cancer.
Hu CE; Liu YC; Zhang HD; Huang GJ
Biochem Biophys Res Commun; 2014 Jun; 449(1):1-7. PubMed ID: 24802408
[TBL] [Abstract][Full Text] [Related]
4. BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.
Kubo T; Kawano Y; Himuro N; Sugita S; Sato Y; Ishikawa K; Takada K; Murase K; Miyanishi K; Sato T; Takimoto R; Kobune M; Nobuoka T; Hirata K; Takayama T; Mori M; Hasegawa T; Kato J
Gastric Cancer; 2016 Jul; 19(3):827-38. PubMed ID: 26486506
[TBL] [Abstract][Full Text] [Related]
5. Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
Xu W; Jiang K; Shen M; Chen Y; Huang HY
Oncol Rep; 2016 Jan; 35(1):352-8. PubMed ID: 26498874
[TBL] [Abstract][Full Text] [Related]
6. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
7. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance.
Cai X; Duan X; Tang T; Cui S; Wu T
BMC Cancer; 2023 May; 23(1):423. PubMed ID: 37165308
[TBL] [Abstract][Full Text] [Related]
8. Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes.
Kitamura S; Tanahashi T; Aoyagi E; Nakagawa T; Okamoto K; Kimura T; Miyamoto H; Mitsui Y; Rokutan K; Muguruma N; Takayama T
Oncology; 2017; 93(2):127-135. PubMed ID: 28511180
[TBL] [Abstract][Full Text] [Related]
9. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p.
Li Y; Wang Y; Xie Z; Hu H
Mol Med Rep; 2019 Apr; 19(4):2489-2496. PubMed ID: 30720092
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
11. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
12. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
13. Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
Saito H; Fushida S; Miyashita T; Oyama K; Yamaguchi T; Tsukada T; Kinoshita J; Tajima H; Ninomiya I; Ohta T
BMC Cancer; 2017 Apr; 17(1):294. PubMed ID: 28449652
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells.
Zhang H; Wang Z; Wang F; Wang C; Zhang H
Arch Biochem Biophys; 2020 May; 684():108334. PubMed ID: 32173334
[TBL] [Abstract][Full Text] [Related]
15. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Kim TD; Shin S; Berry WL; Oh S; Janknecht R
J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
[TBL] [Abstract][Full Text] [Related]
16. A Phase 2 Study of Induction Chemotherapy Using Docetaxel, Cisplatin, and S-1 for Gastric Cancer with Peritoneal Metastasis (KUGC06).
Okabe H; Hata H; Hosogi H; Ueda S; Ota S; Kinjo Y; Hoshino N; Hisamori S; Tsunoda S; Obama K; Sakai Y;
Ann Surg Oncol; 2019 Jun; 26(6):1779-1786. PubMed ID: 30767179
[TBL] [Abstract][Full Text] [Related]
17. REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer.
Sekikawa A; Fukui H; Zhang X; Maruo T; Tsumura T; Okabe Y; Wakasa T; Osaki Y; Chiba T; Tomita T; Oshima T; Watari J; Miwa H
Br J Cancer; 2013 Feb; 108(2):395-401. PubMed ID: 23322208
[TBL] [Abstract][Full Text] [Related]
18. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Sato Y; Ohnuma H; Nobuoka T; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Shinya M; Katsuki S; Takahashi M; Maeda M; Okagawa Y; Naoki U; Kikuch S; Okamoto K; Miyamoto H; Shimada M; Takemasa I; Kato J; Takayama T
Gastric Cancer; 2017 May; 20(3):517-526. PubMed ID: 27553665
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study.
Ohnuma H; Sato Y; Hirakawa M; Kikuchi S; Miyanishi K; Sagawa T; Takahashi Y; Nobuoka T; Okamoto K; Miyamoto H; Takemasa I; Takayama T; Kato J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):539-548. PubMed ID: 29383482
[TBL] [Abstract][Full Text] [Related]
20. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
